BHVN
Biohaven Ltd
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
Market Cap: 4.74 Billion
Primary Exchange: NEW YORK STOCK EXCHANGE INC.
Shares Outstanding: 81.6 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.5934936279638119
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Ethical Flags
Longest drawdown: 429 trading days
From: 2022-09-27 To: 2024-03-07
Lowest Point:
Evidence That Biohaven Is Overvalued
via: SeekingAlpha at 2019-06-12 07:30:48:000
Biohaven (BHVN) is a clinical-stage company developing drugs for migraine treatment and prevention, glutamate dysfunction in Alzheimer's disease ((AD)) and anxiety disorders, and multiple system atrophy. The value of a drug company depends on the estimated demand for their products. In the c… read more...
Evidence That Biohaven Is Overvalued
via: SeekingAlpha at 2019-06-12 07:30:48:000
Biohaven (BHVN) is a clinical-stage company developing drugs for migraine treatment and prevention, glutamate dysfunction in Alzheimer's disease ((AD)) and anxiety disorders, and multiple system atrophy. The value of a drug company depends on the estimated demand for their products. In the c… read more...
BIIB Is For Buy-O-Gen
via: SeekingAlpha at 2019-06-12 06:30:36:000
Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc… read more...
BIIB Is For Buy-O-Gen
via: SeekingAlpha at 2019-06-12 06:30:36:000
Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc… read more...
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|